RPG Life Sciences (RPGLIFE) Stock Overview

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies. It operates in nephrology, rheumatology, oncology, gastroenterology, cardiovascular, orthopedics, respiratory, neurology, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology, pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.